Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 51,865 | 22,786 | 0 | 0 | 0 |
| Cost of Goods | 7,310 | 5,297 | N/A | N/A | N/A |
| Gross Profit | 44,555 | 17,489 | N/A | N/A | N/A |
| Operating Expenses | 37,537 | 21,622 | 0 | 0 | 0 |
| Operating Income | 7,328 | -3,836 | N/A | N/A | N/A |
| Interest Expense | 4,571 | 2,274 | 0 | 0 | 0 |
| Other Income | 2,592 | -248 | 0 | 0 | 0 |
| Pre-tax Income | 5,349 | -6,358 | 0 | 0 | 0 |
| Income Tax | 72 | 9 | N/A | N/A | N/A |
| Net Income Continuous | 5,277 | -6,367 | N/A | N/A | N/A |
| Net Income | $5,277 | $-6,367 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | 0.35 | -5.33 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 0.61 | -3.34 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.21 | -5.33 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 0.61 | -3.34 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.81 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $9,611 | $-2,947 | $N/A | $N/A | $N/A |